ZFP-TFs gene regulation technology designed by Sangamo therapeutics could repressed allele specific gene without affecting the normal allele.

Sangamo therapeutics on July 1 announced publication of a manuscript in Nature Medicine on the activity of allele-specific Zinc Finger Proteins (ZFP-TFs) in models of Huntington’s Disease. The data which was published online on July 1 will appear in the July 2019 issue of Nature Medicine.

Scientists from Sangamo and its collaborators from CHDI foundation have used Zinc Finger Proteins Transcriptions Factors (ZFP-TFs) to selectively targets mutant allele of the Huntington gene (HTT) and repress its expression 99% while retaining 86% of the normal allele.

Huntington is a fatal, progressive, neurodegenerative disorder caused by a dominant mutation involving the expansion of CAG trinucleotide repeat in exon 1 of the HTT gene. Fully penetrant disease alleles of mutant HTT have more than 39 CAG repeats, but most HD patients have one healthy wild-type copy of HTT with less than 22 CAG repeats. Sangamo scientist has developed ZFP-TFs which could bind only to the mutant allele avoiding the normal wild type and repressed its expression. Data from preclinical in vivo studies using different HD mouse models demonstrated improvements in a range of molecular, histopathological, electrophysiological, and other functional endpoints following treatment with Sangamo’s ZFP-TFs.

Finally, extensive in vivo tolerability assessments showed no evidence of a neuroinflammatory response or changes in behavior or locomotor function in mice treated with ZFP-TFs out to 15 months of age.

Sangamo's zinc finger protein transcription factor (ZFP-TFs) gene regulation technology:

IT is designed to either selectively repress (down-regulate) or activate (up-regulate) the expression of a specific gene or gene allele. Sangamo has a collaboration with Pfizer, deploying the ZFP-TF gene regulation approach to repress the expression of the mutated C9ORF72 gene allele linked to genetic forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Sangamo is also developing ZFP-TFs to down-regulate the expression of tau, a protein associated with Alzheimer's disease and other tauopathies.

About Huntington Disease:

Huntington’s disease (HD) is an inherited neurodegenerative disease that typically presents in adults aged between 30 and 50. HD is caused by a mutation in one of the alleles of the huntingtin gene (HTT), leaving only one functional or healthy copy of HTT in the cell. The mutated HTT produces the mutant HTT protein, leading to profound neuronal loss and progressive deterioration of motor, psychiatric, and cognitive abilities. There are currently no disease-modifying therapies available for HD.

Reference: Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease. July Nature Medicine.

https://doi.org/10.1038/s41591-019-0478-3

Comments

Our top Stories

RNA editing, CRISPR-Cas 13 provides herd immunity against dsDNA phage.

CRISPR-cas13: the only RNA editing CRISPR till date. CRISPR RNA targeting CRISPR-cas13 provides immunity against dsDNA phage without cutting the genome, unlike the other 5 types which work by cutting the genome. CRISPR-Cas13 works differently. It provides herd immunity to the bacteria. CRISPR-Cas13 There are six types of CRISPR in literature till now (1-6). CRISPR Cas VI is the only one that cuts the RNA. It cuts the RNA transcript complementary to the target sequence of the mRNA . After cutting the complementary RNA, it starts cutting all other mRNAs of the phage which Scientists called Collateral damage. This is the phenomena that provide Herd immunity. 3D structure of CRIPSR-Cas References: Cas13 Helps Bacteria Play Dead when the Enemy Strikes. Cell Host and Microbe . https://doi.org/10.1016/j.chom.2019.06.012 Follow and like Layman's Biology Facebook page for more news

American Diabetes Association says prediabetes treatment works.

Prediabetes is a condition in which a person has high blood sugar, but not enough to be called Diabetic. This condition is considered a warning sign for the people. The person has a high chance of developing type 2 diabetes if he continues the same lifestyle without any medication. But it is not too late, it's possible to bring a blood sugar level back to normal. Lifestyle changes, weight loss, and medication are believed to help to bring the blood sugar level back to normal. However, its effective has always been controversial. According to American Diabetes Association’s (ADA’s) Professional Practice Committee, they say it has been shown that healthy eating and regular physical activity have been shown (along with the medication metformin for select patients) to delay or prevent progression to diabetes. Reference: Evidence supports prediabetes treatment. Science 26 Apr 2019: ...

Scientists found two anti-viral drugs which kills novel coronavirus (2019-nCOV).

The recent outbreak of coronavirus in Wuhan has infected thousands of people, especially in China. As of till now 30,00 confirmed cases have been reported in mainland China. Additionally, imported cases of coronavirus were identified in many other countries including Thailand, Japan, South Korea, United States, Vietnam, Singapore, Nepal, India, France, Australia, and Canada. The cause of the outbreak has been named novel coronavirus (2019- nCoV ). This virus belongs to the same family as SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV) which cause epidemic and killed many in the early 2000s. The virus is spreading everywhere infecting thousands of innocent people. But there is no drug available for treatment. Scientists around the globe are working their best to develop a drug for the treatment of infected patients. The quickest solution is to check whether we can treat patients using the drugs that are currently available for treating ...

CRISPR can now be used as a drug delivery molecule.

Drugs (or any molecules) could be delivered to the target site and released under the control of CRISPR 12a. CRISPR Cas12a James Collins, MIT, Cambridge used CRISPR to deliver drug molecules . They used water-filled polymers that are held together by strands of DNA, known as DNA hydrogels. To alter the properties of these materials, Collins's team used a form of CRISPR called Cas12a. (The gene-editor CRISPR–Cas9 uses the Cas9 enzyme to snip a DNA sequence at the desired point.) The Cas12a enzyme can be programmed to recognize a specific DNA sequence. The enzyme cuts its target DNA strand, then severs single strands of DNA nearby. This property allowed the researchers to build a series of CRISPR-controlled hydrogels containing a target DNA sequence and single strands of DNA, which breaks up after Cas12a recognizes the target sequence in a stimulus. The break-up of the single DNA strands triggers the hydrogels to change shape or, in some ...

Science Stories

Search This Blog